CaptainObvious,
This is why I spent a good deal of time doing due diligence on Linda early on. I wanted to know her underlying motivations, decisive decision making ability, planning, experience, understanding of the science, foresight as to it’s broad applicability, tenacity and ability to persevere. In biotech it’s about the science, strategy, leadership execution and time. NWBO has derisked every area now to the point that all that’s left is time and that has been reduced dramatically more than the current price suggests but awareness lags because of the strategy. So who should be benefitting the most from understanding this, current investors or the uninformed broader market and who do you think are more friendly towards Linda’s plans, current investors or the general market?; ). Tag, you’re it ; ). Best wishes.